FluCHIM Study

The FluCHIM study is a flu “challenge” project where participants will be infected with a specific strain of the flu in a controlled environment. The study team will follow the course of the infection to learn how the body’s immune system reacts to it. Participants may experience flu symptoms, and will be regularly monitored by our doctors and nurses.

‍

Your involvement could play an important role in improving our understanding of the immune system, which could help in the future development of new and effective vaccines or treatments for the flu, and in improving healthcare globally.

‍

There is a 10 to 11-day stay required for this study where you will not be able to the leave the Doherty Clinical Trials Unit.

‍